tiprankstipranks
Lepu Biopharma Co. Ltd. Class H (HK:2157)
:2157
Hong Kong Market
2157
Lepu Biopharma Co. Ltd. Class H
RESEARCH TOOLSreports
Want to see HK:2157 full AI Analyst Report?

Lepu Biopharma Co. Ltd. Class H (2157) Ratios

4 Followers

Lepu Biopharma Co. Ltd. Class H Ratios

HK:2157's free cash flow for Q4 2025 was ¥0.77. For the 2025 fiscal year, HK:2157's free cash flow was decreased by ¥ and operating cash flow was ¥0.01. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 0.98 0.98 0.62 0.75 0.96
Quick Ratio
 0.94 0.94 0.60 0.72 0.93
Cash Ratio
 0.73 0.73 0.38 0.47 0.79
Solvency Ratio
 0.20 0.20 -0.20 0.05 -0.36
Operating Cash Flow Ratio
 -0.06 -0.03 -0.19 -0.28 -0.57
Short-Term Operating Cash Flow Coverage
 -0.09 -0.05 -0.36 -0.58 -1.34
Net Current Asset Value
¥ -577.18M¥ -577.18M¥ -953.37M¥ -818.46M¥ -815.61M
Leverage Ratios
Debt-to-Assets Ratio
 0.34 0.34 0.37 0.31 0.27
Debt-to-Equity Ratio
 0.76 0.76 1.21 0.83 0.77
Debt-to-Capital Ratio
 0.43 0.43 0.55 0.45 0.43
Long-Term Debt-to-Capital Ratio
 0.17 0.17 0.27 0.22 0.24
Financial Leverage Ratio
 2.24 2.24 3.25 2.66 2.81
Debt Service Coverage Ratio
 0.19 0.23 -0.56 0.19 -1.62
Interest Coverage Ratio
 2.30 3.06 -18.05 0.33 -94.35
Debt to Market Cap
 0.13 0.13 0.19 0.11 0.06
Interest Debt Per Share
 0.60 0.62 0.52 0.46 0.43
Net Debt to EBITDA
 1.34 1.15 -1.44 3.69 -0.04
Profitability Margins
Gross Profit Margin
85.51%80.39%79.66%87.45%87.12%
EBIT Margin
7.18%9.60%-107.63%-6.93%-4443.71%
EBITDA Margin
16.55%19.63%-84.81%38.58%-3830.77%
Operating Profit Margin
5.35%9.60%-106.25%2.13%-4524.03%
Pretax Profit Margin
27.70%27.88%-115.33%-13.45%-4491.66%
Net Profit Margin
27.80%27.96%-111.85%-9.81%-4424.94%
Continuous Operations Profit Margin
27.51%27.69%-115.33%-13.45%-4491.66%
Net Income Per EBT
100.36%100.28%96.98%72.92%98.51%
EBT Per EBIT
517.73%290.39%108.55%-631.80%99.28%
Return on Assets (ROA)
8.31%8.21%-18.04%-0.93%-27.24%
Return on Equity (ROE)
24.17%18.36%-58.53%-2.46%-76.50%
Return on Capital Employed (ROCE)
2.56%4.51%-31.59%0.32%-41.80%
Return on Invested Capital (ROIC)
1.81%3.18%-21.47%0.25%-33.83%
Return on Tangible Assets
9.91%9.79%-21.91%-1.13%-34.93%
Earnings Yield
3.21%3.25%-9.89%-0.35%-6.47%
Efficiency Ratios
Receivables Turnover
 13.85 13.61 8.03 5.96 5.12
Payables Turnover
 0.73 0.97 0.32 0.14 0.01
Inventory Turnover
 2.59 3.44 3.28 0.96 0.08
Fixed Asset Turnover
 0.90 0.89 0.35 0.21 0.02
Asset Turnover
 0.30 0.29 0.16 0.09 <0.01
Working Capital Turnover Ratio
 -4.34 -4.36 -1.19 -1.78 -0.12
Cash Conversion Cycle
 -332.51 -243.10 -995.26 -2.24K -25.79K
Days of Sales Outstanding
 26.34 26.82 45.47 61.23 71.26
Days of Inventory Outstanding
 140.90 105.98 111.16 379.65 4.38K
Days of Payables Outstanding
 499.75 375.90 1.15K 2.68K 30.24K
Operating Cycle
 167.24 132.80 156.63 440.88 4.45K
Cash Flow Ratios
Operating Cash Flow Per Share
 -0.04 -0.02 -0.12 -0.15 -0.29
Free Cash Flow Per Share
 -0.05 -0.05 -0.15 -0.18 -0.36
CapEx Per Share
 <0.01 0.03 0.04 0.02 0.07
Free Cash Flow to Operating Cash Flow
 1.19 2.15 1.31 1.16 1.23
Dividend Paid and CapEx Coverage Ratio
 -5.15 -0.87 -3.18 -6.09 -4.35
Capital Expenditure Coverage Ratio
 -5.15 -0.87 -3.18 -6.09 -4.35
Operating Cash Flow Coverage Ratio
 -0.07 -0.04 -0.23 -0.34 -0.70
Operating Cash Flow to Sales Ratio
 -0.08 -0.04 -0.53 -1.11 -30.88
Free Cash Flow Yield
-1.05%-1.06%-6.21%-4.61%-5.55%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 31.13 30.77 -10.11 -286.50 -15.45
Price-to-Sales (P/S) Ratio
 8.65 8.60 11.31 28.09 683.76
Price-to-Book (P/B) Ratio
 5.78 5.65 5.92 7.06 11.82
Price-to-Free Cash Flow (P/FCF) Ratio
 -95.18 -94.63 -16.11 -21.68 -18.00
Price-to-Operating Cash Flow Ratio
 -113.69 -203.19 -21.18 -25.24 -22.14
Price-to-Earnings Growth (PEG) Ratio
 0.07 -0.19 >-0.01 2.96 0.50
Price-to-Fair Value
 5.78 5.65 5.92 7.06 11.82
Enterprise Value Multiple
 53.61 44.98 -14.77 76.50 -17.88
Enterprise Value
 8.22B 8.04B 4.61B 6.65B 10.67B
EV to EBITDA
 53.61 44.98 -14.77 76.50 -17.88
EV to Sales
 8.87 8.83 12.53 29.51 685.11
EV to Free Cash Flow
 -97.60 -97.11 -17.85 -22.78 -18.04
EV to Operating Cash Flow
 -116.54 -208.51 -23.47 -26.52 -22.18
Tangible Book Value Per Share
 0.49 0.50 0.16 0.27 0.21
Shareholders’ Equity Per Share
 0.77 0.79 0.42 0.54 0.55
Tax and Other Ratios
Effective Tax Rate
 <0.01 <0.01 0.00 0.00 0.00
Revenue Per Share
 0.51 0.52 0.22 0.14 <0.01
Net Income Per Share
 0.14 0.15 -0.24 -0.01 -0.42
Tax Burden
 1.00 1.00 0.97 0.73 0.99
Interest Burden
 3.86 2.90 1.07 1.94 1.01
Research & Development to Revenue
 0.40 0.37 1.19 2.03 33.67
SG&A to Revenue
 0.36 0.34 0.65 0.38 8.92
Stock-Based Compensation to Revenue
 0.00 0.00 0.01 0.08 1.95
Income Quality
 -0.27 -0.15 0.46 11.35 0.69
Currency in CNY